This advert is not available!
The prospective postdoctoral researcher will be recruited to the Team Translational Vascular Medicine led by PI Ass Prof Ljubica Matic, MSc, PhD. This Team is integrated within the large Vascular Surgery research group, MMK, KI, which is dedicated to translational and clinical research on vascular diseases and pathological vascular conditions in general. The Team Translational Vascular Medicine is specialized in molecular mechanisms underlying atherosclerosis and vascular injury. This Team is situated at the new BioClinicum building, it belongs also to the Center for Molecular Medicine and gathers several PhD students and postdocs. More information can be found at:https://ki.se/mmk/members-of-team-ljubica-matic
The vascular diseases and conditions addressed in our research are atherosclerosis, aortic aneurysms, peripheral arterial disease as well as restenosis after vascular interventions. Altogether these conditions contribute to the high overall cardiovascular mortality, dominated by complications of atherosclerosis such as myocardial infarction or stroke. In order to better understand the development and progression of vascular disease, our aim is to dissect and explore the cellular behavior and molecular pathways in complex vascular tissues. Over the past decades we have, together with the Vascular Surgery Clinic, Karolinska Hospital, assembled several large biobanks of human and murine vascular tissues (i.e. BiKE-Biobank of Karolinska Endarterectomies; STAAAB-Stockholm Abdominal Aortic Aneurysm Biobank; BiRCA-Biobank of Rat Carotid Artery injury, etc.). Our platform enables large-scale multivariate analyses of gene and protein expression from vascular lesions and blood, combined with genetic and clinical parameters, as well as follow up studies in animal and cell culture models of vascular injury and disease.
The overall goal of the proposed project, with Ass Prof Ljubica Matic as the PI, is to explore one of the targets/pathways previously identified by large-scale omics analyses of human atherosclerosis and animal studies, with the aim to develop novel treatment options targeting unstable atherosclerosis. The postdoc will explore the biology of one recently discovered candidate protein, which we have found to play a key role in smooth muscle cell activation and modulation during vascular remodeling and atheroprogression. The postdoc will further evaluate this candidate as a desirable drug target with respect to various alternative possibilities of targeting this pathway in metabolic control. More specifically, the project will be based on characterization studies in murine models in vivo and in vitro, utilizing relevant models for mimicking vascular injury and atherosclerosis, as well as metabolic models of liver disease and diabetes, combined with modulation of the expression of this target. The postdoc will work with both full and conditional knock-out mice for this target, which are already in house and available for the studies. Importantly, the work will practically encompass microsurgery on mice and rats, primary cell isolations, sophisticated in vitro studies, histology and microscopy, as well as managing different collaborations and core facilities for analyses.
The project holds translational potential in opening new opportunities for improved treatment of patients with cardiovascular disease, but also carries considerable novelty in the research field. We offer a position in one of the leading groups in the field of vascular disease with an excellent network of international collaborators and longstanding experience in translational science. The project will be conducted in a multidisciplinary environment at the interface between academia and big pharma industry, where resources and expertise in animal surgery, clinical patient material processing and bioinformatics will be available. However, excellent experimental methodological skill and dedication will be necessary for successfully conducting the project
Qualified to be employed as a postdoctor is one who has obtained a doctorate or has equivalent scientific competence. Applicants who have not completed a doctorate at the end of the application period may also apply, provided that all requirements for a completed degree are met before the (intended) date of employment. This must be substantiated by the applicant's main supervisor, director or equivalent.
The suitable candidate should have a biomedical, cell/molecular biology or pharmaceutical, background and interest in the complex pathophysiology at the intersection between vascular and metabolic diseases. We are looking for a highly motivated person that should be dedicated to full time experimental research, have the potential to work both independently and within a translational team, and manage the close collaboration between academia, clinic and pharma industry. The daily work is laboratory based and includes state-of-the-art in vivo, in vitro and in situ molecular techniques, situated in modern new laboratories. Willingness to work with animals is a requirement and previous practical experience in animal and cell culture experimentation will be considered necessary. Additional experience in omics data bioinformatic analyses and tissue processing for histology will be assessed as highly meritorious.
The appointed person will be expected to plan, perform, analyze and interpret experimental results independently and within the Team, present at congresses, and participate in national/international collaboration networks. Willingness to work flexibly in order to achieve project demands and targets as agreed within a Team is necessary. Being able to organise and prioritise own work, as well as organising research within the project timetable and planned deliverables is essential. Maintaining accurate and up to date records is necessary. Fluency in English is a requirement, knowledge of Swedish is not necessary but is an advantage. Good social and analytical skills are essential. Ability to travel to other countries is essential and possibilities will exist for conducting research visits abroad.
Karolinska Institutet is one of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote better health for all. At Karolinska Institutet, we conduct innovative medical research and provide the largest range of biomedical education in Sweden. Karolinska Institutet is a state university, which entitles employees to several benefits such as extended holiday and a generous occupational pension. Employees also have free access to our modern gym and receive reimbursements for medical care.
Location: Solna
A selection will be made among qualified applicants on the following basis proposed by the Karolinska Institutet:
- Documented research experience and analytical skills
- Documented subject knowledge of relevance to the area of research
- Scientific articles and a track record of publications in international peer-reviewed journals
- Excellent communication skills
- Ability to manage complex projects both independently and within collaborations, particularly at the interface between clinical and laboratory staff, as well as between academia and pharmaceutical industry
- Experience and ability to supervise students and undertake teaching activities
The qualifications of the applicants will be evaluated on an overall basis. Personal suitability is an important criterion.
An employment application must contain the following documents in English or Swedish:
Welcome to apply at the latest xxx
The application is to be submitted through the Varbi recruitment system.
Type of employment | Temporary position |
---|---|
Contract type | Full time |
Salary | Månadslön |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Stockholm |
County | Stockholms län |
Country | Sweden |
Reference number | STÖD 2-959/2021 |
Contact |
|
Union representative |
|
Published | 19.Feb.2021 |
Last application date | 21.Mar.2021 11:59 PM CET |